Invitation to multi-omics 2026 - Brisbane, Australia
Meeting start: 08:00 Sunday 6 December
Meeting end: 20:00 Tuesday 8 December 2026
On behalf of the organising committee, we are delighted to invite you to join us at Multi-Omics 2026, held at the Brisbane Convention & Exhibition Centre, Queensland, Australia, from 6–8 December 2026.
Multi-Omics at the Frontier of Disease Biology
Multi-omics technologies, propelled by rapid innovation in spatial biology, digital pathology, and AI are reshaping our understanding of human disease. From cancer and immunology to infectious disease, the field has evolved from promise to precision, unlocking new layers of insight across tissues, timepoints, and therapeutic contexts.
What to Expect
Over three dynamic days, Multi-Omics 2026 will spotlight the latest breakthroughs in:
Spatial Biology Methods and Applications
Spatial Medicine
Computational Biology
AI-powered Omics Analytics
Sessions will span immuno-oncology, infectious disease, and computational immunology, with a strong emphasis on experimental design, cohort architecture, and translational impact.
JOIN US IN THE FIGHT TO CURE CANCER!
What if the next cancer breakthrough started right here?
Multiomics 2026 is proud to fundraise for Cure Cancer, an Australian charity backing brilliant emerging researchers and the bold new ideas that can change cancer outcomes. Every dollar raised through the conference, from our on-site swag store to the gala dinner, helps kickstart the kind of brave, early-stage research that often struggles to find support elsewhere.
Cure Cancer has funded more than 570 research projects across every cancer type, large and small, rare and common. Their seed grants have helped launch careers, contributed to Australia's national HPV vaccination rollout, and supported early detection breakthroughs that change lives. As a proud former Cure Cancer grant recipient, I have seen firsthand what a leap of imagination, and the right support at the right time, can do.
Donate online using the QR code, shop the swag store on-site, or bid on special items going for auction. Every contribution fuels the next big idea.
What if we cure cancer? We know we can.
Why Attend?
This meeting brings together a critical mass of national and international leaders in multi-omics, offering:
Cutting-edge science and real-world datasets
Platform launches and hands-on technical workshops
Engagement with leading technology providers
A collaborative space to shape the future of precision medicine
Whether you're decoding spatial signatures, refining analytical pipelines, or driving clinical translation, Multi-Omics 2026 is your launchpad.
We look forward to welcoming you to Brisbane, where discovery meets translation.
2024 highlights
Hear from the world leaders in 2026!
2026 SPEAKERS
-
JOE BEECHEM
Bruker Spatial Biology Chief Scientific Officer.
-
SARAH BEST
Laboratory Head and fundamental biology lead in the Brain Cancer Research Lab
-
Carlo Bifulco
Chief Medical Officer & Medical Director
Providence Genomics & Providence Cancer Institute, USA -
JENNIFER BOROWSKY
Anatomical & Molecular Pathologist, Queensland Health, Australia
-
Oliver Braubach
Director of Research & Development at Bruker Spatial Biology
-
TULLIA BRUNO
Assistant Professor in the Department of Immunology at the University of Pittsburgh, USA
-
Caroline Cooper
Anatomical Pathologist, Pathology Queensland, Princess Alexandra Hospital, Australia
-
Jessica Da Gama Duarte
Laboratory Head, Department of Cancer Medicine, School of Translational Medicine, Monash University, Australia
-
Rong Fan
Harold Hodgkinson Professor of Biomedical Engineering, Yale University, USA
-
Alistair Forrest
Head of Systems Biology and genomics Laboratory and Associate Director, Harry Perkins Institute of Medical Research, University of Western Australia. Australia
-
FERNANDO GUIMARAES
Associate Professor & Group Leader, Frazer Institute, University of Queensland, Australia
-
ANNABELLE GURWITCH
Best selling author, USA
-
Ruby Huang
Program Director
Smart MHI Program, International College, National Taiwan University, Taiwan -
Helen McGuire
Associate Professor
Faculty of Medicine and Health, University of Sydney, Australia -
Miranda Orr
Associate Professor
Washington University in St Louis, USA -
MAINTHAN PALENDIRA
Academic Director of Sydney Cytometry Core Facility
The University of Sydney, NSW, Australia
-
JIWOON PARK
Postdocoral Researcher at Weill Cornell Medicine & Harvard Medical School, USA.
-
JASMINE PLUMMER
Founding Director of the Center for Spatial Omics at St Jude Children’s Research Hospital, USA
-
Hoifung Poon
General Manager, Real-World Evidence, Microsoft Research, USA
-
Niro Ramachandran
Global Head of Marketing, 10x Genomics
-
Agus Salim
Associate Professor in Biostatistics, University of Melbourne, Australia
-
Somponnat Sampattavanich
Assistant Professor
Department of Pharmacology, Mahidol University, Thailand -
DENIS SCHAPIRO
Group Leader in Spatial omics, Heidelberg University Hospital, Germany
-
Christian Schürch
Professor
University Hospital Tübingen, Germany -
Michael Schnall-Levin
Chief Technology & Strategy Officer, Founding Scientist, 10x Genomics
-
MARTIN SMITH
Director of the Ramaciotti Centre for Genomics, University of NSW, Australia
-
Mitchell Stark
Associate Professor and NHMRC Investigator Fellow, Frazer Institute, University of Queensland, Australia
-
MATT TRAU
Director, Centre for Personalised Nanomedicine
The University of Queensland -
Orazio Vittorio
The University of NSW, Australia
-
PAUL WARING
Director: Translational Pathology Consulting Services Ltd, Oxford UK
-
JAMES WILMOTT
Melanoma Institute Australia, The University of Sydney, Australia
-
Joe Yeong
Director of ImmunoPathology
Singapore General Hospital, Singapore
ORGANISING COMMITTEE
STAY CONNECTED
Fill in your details to join the mailing list and keep up to date with the latest Multi-Omics news and information, including speaker announcements, key dates and program information.